Visit COVID-19 resources

[Skip to Content]

Intravitreal bevacizumab for choroidal metastases: the key to efficacy is simultaneous administration of systemic therapy – (Eye 29, 1629 (December 2015))

10 December 2015

This news item is available to RCOphth members only, please log in below to access.

Members Login